Publications
462
Citations
26,725
Est. group size
~1
Recurring co-author estimate
Active years
38
Publishing since 1989
Linda A. DiMeglio conducts clinical research on type 1 diabetes, with a particular focus on children and youth. Her work covers new treatment methods (such as inhaled insulin and immune-based therapies), early detection through antibody testing, and how the disease progresses through different stages. She also studies related pediatric topics like bone conditions and growth.
Publication activity has been consistently high over the past decade, averaging around 30-40 papers per year through 2024, with fewer counts in 2025-2026 likely reflecting incomplete recent indexing.
Generated by claude-opus-4-8 from public bibliographic data · Jul 9, 2026
Current awards run through June 2029 — about 3 years of funding on record from today. Awards are often renewed, so this is what is currently public, not a forecast.
Neurocognitive Effects of Type 1 Diabetes in Young Children: Indiana University Clinical Center
4 earlier awards
- NIH U01DK107014Jul 2015 – Apr 2020 · $450k awarded
Type 1 Diabetes TrialNet at Indiana University Clinical Center
- NIH U01DK085505Sep 2009 – Jul 2015 · $247k awarded
Type 1 Diabetes TrialNet at Indiana University Clinical Center
- NIH M01RR000750Dec 2003 – May 2008 · $1k awarded
BISPHOSPHONATE THERAPY FOR CHILDHOOD OSTEOPOROSIS
- NIH K23RR015538May 2000 – Apr 2006 · $117k awarded
Mentored Patient Oriented Research Career Development Aw
Matched to public NIH RePORTER and NSF records by name and institution. Awards from other agencies are not shown, and a match is not always found — this list may be incomplete.
Typically publishes in teams of ~11 · 10% small-team papers (≤3 authors) · across 69 venues
- Inhaled Technosphere Insulin Reduces Postmeal Glucose Excursion in Youth Living with Type 1 Diabetes
Diabetes Technology & Therapeutics · 2026
- Accuracy of glutamic acid decarboxylase antibodies for the identification of adult-onset type 1 diabetes mellitus: a systematic review and meta-analysis
Frontiers in Endocrinology · 2026
- Safety and pharmacokinetics of teplizumab in children less than 8 years of age with stage 2 type 1 diabetes
Diabetologia · 2025
- INHALE-1: A Multicenter Randomized Trial of Inhaled Technosphere Insulin in Children With Type 1 Diabetes
Diabetes Care · 2025
- Associations of CGM Metrics with Stimulated C-Peptide Measures in Youth with Recent-Onset Type 1 Diabetes
2025
- Associations of CGM Metrics with Stimulated C-Peptide Measures in Youth with Recent-Onset Type 1 Diabetes
2025
- 1508-P: Longitudinal Autoantibody Variation in Stage 3 Type 1 Diabetes
Diabetes · 2025
- 712-P: Understanding Participant Decision Making for Enrolling in an Intervention Trial to Delay Stage 3 T1D
Diabetes · 2025
- 1507-P: Age and Sampling Times Significantly Affect Autoantibody Measurement in Stage 3 Type 1 Diabetes
Diabetes · 2025
- Perceptions of the Benefits and Risks of Novel Therapies for Type 1 Diabetes: A Qualitative Study
Diabetes Therapy · 2025
- INHALE-1: A Multi-center Randomized Trial of Inhaled Technosphere Insulin in Children with Type 1 Diabetes
2025
- INHALE-1: A Multi-center Randomized Trial of Inhaled Technosphere Insulin in Children with Type 1 Diabetes
2025
- Brief Report: Is Gestational Exposure to HIV and Protease Inhibitors Associated With Timing of Pubertal Onset?
JAIDS Journal of Acquired Immune Deficiency Syndromes · 2025
- INHALE-1: A Multi-center Randomized Trial of Inhaled Technosphere Insulin in Children with Type 1 Diabetes
2025
- Development and Methodology of the 2024 and 2026 ISPAD Clinical Practice Guidelines
Hormone Research in Paediatrics · 2025
- Diabetes×43
- Diabetes Care×36
- Pediatric Diabetes×18
- Communications Medicine×16
- Diabetologia×10
- Manmohan K. Kamboj
Medicine · The Ohio State University
- Tamara S. Hannon
Medicine · Indiana University
- Robin Goland
Medicine · University of Michigan
- Don Buckingham
Medicine · The Ohio State University
- William V. Tamborlane
Medicine · University of Michigan
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Sep 1, 2026.
Claim or correct this profile